Management of oligometastatic/metastatic sarcomas and place of local treatments with focus on modern radiotherapy approaches

Cancer Radiother. 2024 Feb;28(1):93-102. doi: 10.1016/j.canrad.2023.06.029. Epub 2024 Jan 11.ABSTRACTSoft tissue sarcomas are a rare and heterogeneous disease. For localized disease, treatment is based on surgery and radiotherapy with or without chemotherapy depending on risk factors. Upfront metastases are present in 7 to 20% of cases, and are localized to the lungs in most of cases. Disseminated disease is generally considered incurable but in selected cases, aggressive local treatment of metastases allowed long survival. Treatment of primary tumour is often debated. Our purpose is to evaluate the literature concerning the role of radiotherapy in the management of primary metastatic soft tissue sarcomas.PMID:38212215 | DOI:10.1016/j.canrad.2023.06.029

Source: Cancer Radiotherapie - January 11, 2024 Category: Cancer & Oncology Authors: C Llacer-Moscardo L Moureau-Zabotto L Ollivier S Helfr é A Ducassou S Bonvalot M-P Sunyach P Sargos P Gillon N Firmin C Le P échoux J Thariat Source Type: research